The study evaluated the survival and treatment outcomes of African American (AA) patients with lupus nephritis (LN) compared to white patients. AA patients had a higher proportion of class V LN at presentation but similar baseline characteristics in terms of age, blood pressure, BMI, diabetes, serum creatinine, proteinuria, complement levels, autoantibody positivity, and ANA positivity. Overall, AA patients had shorter survival compared to white patients, and AA patients without immunotherapy (IMT) had shorter survival compared to white patients without IMT. However, AA patients with IMT did not show a significant difference in survival compared to white patients with IMT. The study concluded that IMT reduces the risk of progression to end-stage renal disease and helps close the racial gap in survival between AA and white patients.The study evaluated the survival and treatment outcomes of African American (AA) patients with lupus nephritis (LN) compared to white patients. AA patients had a higher proportion of class V LN at presentation but similar baseline characteristics in terms of age, blood pressure, BMI, diabetes, serum creatinine, proteinuria, complement levels, autoantibody positivity, and ANA positivity. Overall, AA patients had shorter survival compared to white patients, and AA patients without immunotherapy (IMT) had shorter survival compared to white patients without IMT. However, AA patients with IMT did not show a significant difference in survival compared to white patients with IMT. The study concluded that IMT reduces the risk of progression to end-stage renal disease and helps close the racial gap in survival between AA and white patients.